| Drug NDC: | 43742-0772 |
| The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC. | |
| Proprietary Name: | Male Stimulant |
| Also known as the trade name. It is the name of the product chosen by the labeler. | |
| Product Type: | Human Otc Drug |
| Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing. | |
| Non Proprietary Name: | Aralia Quinquefolia, Agnus Castus, Ascorbicum Acidum, Caladium Seguinum, Kali Bromatum, Strychninum Phosphoricum, Cantharis, Damiana, Funiculus Umbilicalis Suis, Glandula Suprarenalis Suis, Hypophysis Suis, Orchitinum (suis), Prostate (suis), Conium Maculatum, Diencephalon (suis), Heart (suis), Ferrum Phosphoricum, Magnesia Phosphorica, Selenium Metallicum, Zincum Metallicum, Pineal Gland (suis), Cortisone Aceticum, Manganum Phosphoricum, Lycopodium Clavatum, Testosterone, Morgan Gaertner |
| Also known as the generic name, this is usually the active ingredient(s) of the product. | |
| Labeler Name: | Deseret Biologicals, Inc. |
| Name of Company corresponding to the labeler code segment of the ProductNDC. | |
| Dosage Form: | Liquid |
| The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources. | |
| Status: | Active |
| FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved. | |
| Substance Name: | AMERICAN GINSENG - 4 [hp_X]/mL ASCORBIC ACID - 6 [hp_X]/mL CHASTE TREE - 6 [hp_X]/mL CONIUM MACULATUM FLOWERING TOP - 8 [hp_X]/mL CORTISONE ACETATE - 13 [hp_X]/mL DIEFFENBACHIA SEGUINE - 6 [hp_X]/mL FERROSOFERRIC PHOSPHATE - 10 [hp_X]/mL LYCOPODIUM CLAVATUM SPORE - 28 [hp_X]/mL LYTTA VESICATORIA - 8 [hp_X]/mL MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE - 10 [hp_X]/mL Load more... MANGANESE PHOSPHATE, DIBASIC - 20 [hp_X]/mL PORK HEART - 8 [hp_X]/mL POTASSIUM BROMIDE - 6 [hp_X]/mL SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR ENTERITIDIS - 30 [hp_C]/mL SELENIUM - 10 [hp_X]/mL STRYCHNINE PHOSPHATE DIHYDRATE - 6 [hp_X]/mL SUS SCROFA ADRENAL GLAND - 8 [hp_X]/mL SUS SCROFA DIENCEPHALON - 8 [hp_X]/mL SUS SCROFA PINEAL GLAND - 12 [hp_X]/mL SUS SCROFA PITUITARY GLAND - 8 [hp_X]/mL SUS SCROFA PROSTATE - 8 [hp_X]/mL SUS SCROFA TESTICLE - 8 [hp_X]/mL SUS SCROFA UMBILICAL CORD - 8 [hp_X]/mL TESTOSTERONE - 30 [hp_X]/mL TURNERA DIFFUSA LEAFY TWIG - 8 [hp_X]/mL ZINC - 10 [hp_X]/mL |
| This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted. | |
| Route Details: | ORAL |
| The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. | |
| Marketing Category: | UNAPPROVED HOMEOPATHIC |
| Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. | |
| Marketing Start Date: | 08 Jun, 2016 |
| This is the date that the labeler indicates was the start of its marketing of the drug product. | |
| Marketing End Date: | 16 Jul, 2023 |
| This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached. | |
| Listing Expiration Date: | 05 May, 2026 |
| This is the date when the listing record will expire if not updated or certified by the firm. | |
| Manufacturer Name: | Deseret Biologicals, Inc. |
| Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC. | |
| Original Packager: | Yes |
| Whether or not the drug has been repackaged for distribution. | |
| NUI: | N0000193618 M0001797 N0000175824 N0000000146 M0001109 |
| Unique identifier applied to a drug concept within the National Drug File Reference Terminology (NDF-RT). | |
| UNII: | 8W75VCV53Q PQ6CK8PD0R 433OSF3U8A Q28R5GF371 883WKN7W8X 01800C6E6B 91GQH8I5F7 C88X29Y479 3Q034RO3BT HF539G9L3Q Load more... VZ3U1H7Q5B X876KJM95L OSD78555ZM Y3V16D4PV4 H6241UJ22B TD67SYY51D 398IYQ16YV 23PJ4252VL 050QZ2EDK7 L0PFEMQ1DT O6UD3347K2 KM02613O28 118OYG6W3H 3XMK78S47O RQ2CFA7WWJ J41CSQ7QDS |
| Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information. | |
| Pharmacologic Class MOA: | Androgen Receptor Agonists [MoA] |
| Mechanism of action of the drug—molecular, subcellular, or cellular functional activity—of the drug’s established pharmacologic class. Takes the form of the mechanism of action, followed by `[MoA]` (such as `Calcium Channel Antagonists [MoA]` or `Tumor Necrosis Factor Receptor Blocking Activity [MoA]`. | |
| Pharmacologic Class EPC: | Vitamin C [EPC] Androgen [EPC] |
| Established pharmacologic class associated with an approved indication of an active moiety (generic drug) that the FDA has determined to be scientifically valid and clinically meaningful. Takes the form of the pharmacologic class, followed by `[EPC]` (such as `Thiazide Diuretic [EPC]` or `Tumor Necrosis Factor Blocker [EPC]`. | |
| Pharmacologic Class CS: | Ascorbic Acid [CS] Androstanes [CS] |
| Chemical structure classification of the drug product’s pharmacologic class. Takes the form of the classification, followed by `[Chemical/Ingredient]` (such as `Thiazides [Chemical/Ingredient]` or `Antibodies, Monoclonal [Chemical/Ingredient]. | |
| Pharmacologic Class: | Androgen Receptor Agonists [MoA] Androgen [EPC] Androstanes [CS] Ascorbic Acid [CS] Calculi Dissolution Agent [EPC] Corticosteroid Hormone Receptor Agonists [MoA] Corticosteroid [EPC] Increased Large Intestinal Motility [PE] Inhibition Large Intestine Fluid/Electrolyte Absorption [PE] Inhibition Small Intestine Fluid/Electrolyte Absorption [PE] Magnesium Ion Exchange Activity [MoA] Magnetic Resonance Contrast Activity [MoA] Osmotic Activity [MoA] Osmotic Laxative [EPC] Paramagnetic Contrast Agent [EPC] Stimulation Large Intestine Fluid/Electrolyte Secretion [PE] Vitamin C [EPC] |
| These are the reported pharmacological class categories corresponding to the SubstanceNames listed above. | |
| Package NDC | Description | Marketing Start Date | Marketing End Date | Sample Available |
|---|---|---|---|---|
| 43742-0772-1 | 30 mL in 1 BOTTLE, DROPPER (43742-0772-1) | 08 Jun, 2016 | 16 Jul, 2023 | No |
| Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together. | ||||
* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.